Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166347 · ClinicalTrials.gov registry record · NA
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 451
- Enrollment target
NCT01166347 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 451 participants.
The verdict
NCT01166347, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 451 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of the HeartWare Ventricular Assist System in patients with chronic Stage D/ New York Heart Association (NYHA) Class IIIB/IV left ventricular failure who have received and failed optimal medical therapy, and who are ineligible for cardiac transplantation.
Interventions
- DEVICE HeartWare® VAS
- DEVICE Control LVAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2010-08 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01166347
The ClinicalTrials.gov registry entry for NCT01166347 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 451 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HeartWare® VAS is the first listed.
NCT01166347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01166347 about?
NCT01166347 is a clinical study titled "The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial". The purpose of this study is to determine the safety and effectiveness of the HeartWare Ventricular Assist System in patients with chronic Stage D/ New York Heart Association (NYHA) Class IIIB/IV left ventricular failure who have received and failed optimal medical therapy, and who are ineligible fo...
What is the current status of trial NCT01166347?
This trial is currently completed. It is a NA study. The enrollment target is 451 participants. The study started on 2010-08. Estimated completion is 2017-05.
What interventions are being tested in trial NCT01166347?
The interventions under investigation include: HeartWare® VAS (DEVICE), Control LVAD (DEVICE).
Who is sponsoring clinical trial NCT01166347?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.